Maxigen Biotech Inc. (MBI) was formed by a group of entrepreneurs and scientists in December 1998. We have utilized our core competence in biopolymers, such as collagen and hyaluronic acid, and developed a broad range of medical devices for orthopedic, ophthalmic, dental and surgical applications. We are also developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products with our core technology in collagen and hyaluronic acid. In accordance to the growing trend of minimally invasive surgery, MBI has also developed several biomedical applications, such as injectable bone graft and anti-adhesive. Our biomedical products have received market approval and certification for Taiwan, US and the EU market, and have been successfully launched on the US, Southeast Asia, the Middle East, and other new emerging markets. We are regularly Selling: dermal filler, collagen wound dressing, bone graft substitute, intra-articular injection, ophthalmic viscosurgical device. |
|
|